The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? - Wikidata - wikimedia - TriplyDB

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

http://www.wikidata.org/entity/Q34580212

about

Mendelian randomization studies: a review of the approaches used and the quality of reporting Mendelian Randomization and Type 2 Diabetes Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study Mendelian randomization studies of biomarkers and type 2 diabetes.Lipoprotein (a): impact by ethnicity and environmental and medical conditions Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature.Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity.Structure, function, and genetics of lipoprotein (a).Insight into rheumatological cause and effect through the use of Mendelian randomization.Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey.Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin.Effectiveness of a standard secondary coronary prevention program: not obligate.Correcting the Standard Errors of 2-Stage Residual Inclusion Estimators for Mendelian Randomization Studies.Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes.

P2860

Q26999349-52FAF779-219D-4C66-848D-95B5E5F45791 Q28072229-7B1D7924-812B-4BC9-9A1F-4F26AC66BEBF Q28079294-FF32A1AB-32AF-46F0-957E-2305764D9C79 Q30242031-EA895983-064F-41EA-B2A5-38D79E70CCA1 Q33693705-C5FC34F4-FB7D-4ED6-977C-70CB3CA1B9F7 Q35217061-95ACE8FC-4E74-4DE2-950A-6E0CEAB6620A Q35735742-DEEB21F2-21B2-4C4D-A2B3-A1F2C74CC63B Q36302962-184C0112-4DE4-4E49-A277-2F520EE10FAD Q37033161-5AFF25C4-7BA5-4AFB-ACF2-BAF3145F67D7 Q37334501-0D0A9436-E3C1-4D25-B5A8-FE2EC2CA9842 Q37713534-25FE1BB1-5B24-4203-87AF-B9399BE18F21 Q38213328-C9ADFF5A-0BC9-4403-A434-D6BEEE5DAD2C Q38807488-F7D4E050-46FC-47BE-BB8A-1E70D0BFC62E Q38895577-E94CA52A-8EFC-4325-A6DA-43A041C6E9A2 Q39184189-1A35681B-D28F-4403-9C1E-F861ABD0A2AB Q40060033-5601BA30-CD79-4E4C-B83A-BD78E27F2D55 Q42318540-A09BC0E0-2906-4E0B-B57A-3A9E1A9218A8 Q47652752-F711FD91-2275-4168-B296-9E774C3D9A2E Q48301417-72CBE1A8-8711-4E1D-BD47-8ECA6B742DB3 Q49629329-9D1AB6BE-BFA6-45BF-98D8-1CA9280303E4 Q50933452-195A605E-334C-40A5-8906-F9AE4113F001

P2860

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

http://www.wikidata.org/entity/Q34580212

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The association between circulating lipoprotein

@nl

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@ast

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@en

type

label

The association between circulating lipoprotein

@nl

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@ast

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@en

prefLabel

The association between circulating lipoprotein

@nl

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@ast

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@en

P1433

Q34580212-9B66D37D-7D6A-473D-9B3A-EE885A966F7D

P1476

Q34580212-27E67689-6B7D-454C-B905-F3CFE7181B20

P2093

Q34580212-0684E0B9-F32F-400F-AA37-D50825E68B09

Q34580212-0DF24C27-CBF1-48E0-B0D1-017F75430118

Q34580212-0FD89F3F-A360-4ED8-8015-43A702B0E3B0

Q34580212-36FB9AE1-C9BF-492A-B7F1-FD5ED092248D

Q34580212-7FE3E390-B83F-482E-9077-6B4BB3D49A19

Q34580212-AB016B50-4DC2-4E98-8AF3-0170531C81FE

P2860

Q34580212-00384B60-1266-4BB2-A27C-3117554027D6

Q34580212-0DA38C31-7534-4F7F-8D1B-CE4FC29EF80D

Q34580212-0E3D42AF-664A-4C74-88EF-1E3444A19295

Q34580212-1389E4FA-0FF0-48F9-A10B-0B6AA8E55C23

Q34580212-1E49372B-AA44-4405-A3B4-430253B338E3

Q34580212-20546FBC-DCDF-42EE-A2A4-0FCA485DB811

Q34580212-27BCF4C4-ABFC-4E48-A801-BA0EC104D6A4

Q34580212-27CC6044-1BC3-47E2-8E25-170BB0755EC5

Q34580212-282824E8-4806-416F-9A4C-ACA48B753E16

Q34580212-2F0F46CC-2CFE-4889-800F-C16CFF5F9F9C

P304

Q34580212-C2DBD5A8-F8D6-440C-9022-BD9C2442C24D

P31

Q34580212-AAFC028D-942E-4C5B-806D-9624E2C5A8BA

P356

Q34580212-CAFE9E53-80F4-4C99-8650-9035CF0FA0CD

P407

Q34580212-7B57B10B-95ED-4A8B-8FB0-841F40D9666A

P433

Q34580212-0CB52B6D-D7F7-4FCD-AE78-D3AC8C0C53E2

P478

Q34580212-67EA82BD-BCAE-4B39-B27B-6E3E7C55DC20

P50

Q34580212-02311D8C-2FEB-41F7-9F8E-B03629CA77C2

Q34580212-167317D9-CE7C-4ABC-90E2-3CA60E1F11F7

Q34580212-5712A7C3-1753-40B2-8C1B-94D3762DF428

Q34580212-850103D5-F95E-4E7C-A6DC-57E42B32D806

P577

Q34580212-CAC53494-F0F2-4570-ABA2-8742CB1FA751

P5875

Q34580212-5AF97719-351B-4D59-9478-CDF070E04BE9

P698

Q34580212-4622463A-C680-4D53-8717-F4BA3E9C2E33

P921

Q34580212-31F0D276-3C04-4B1C-B8E4-F2F2DBE035C7

Q34580212-45F6B8BB-5802-4FA2-AF06-E56C1B929542

Q34580212-754D3094-0531-45D9-9628-A33A0CF31F84

P932

Q34580212-2A0D9120-2673-4976-9DDB-EA03CF4A5892

P356

P1433

P1476

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?

@en

P2093

Cristina Pomilla

http://www.w3.org/2001/XMLSchema#string

Deepti Gurdasani

http://www.w3.org/2001/XMLSchema#string

Manjinder S Sandhu

http://www.w3.org/2001/XMLSchema#string

Philip C Haycock

http://www.w3.org/2001/XMLSchema#string

S Matthijs Boekholdt

http://www.w3.org/2001/XMLSchema#string

Zheng Ye

http://www.w3.org/2001/XMLSchema#string

P2860

High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

Lipoprotein(a) and risk of type 2 diabetes

Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study

Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.

The relationship between lipoprotein(a) and the complications of diabetes mellitus.

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

P304

332-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB13-1144

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Nita G. Forouhi

Nicholas J Wareham

Sotirios Tsimikas

P577

2013-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257310375

http://www.w3.org/2001/XMLSchema#string

P698

24089516

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4246060

http://www.w3.org/2001/XMLSchema#string